Related Experiment Video
Updated: Jul 29, 2025

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
Trends in Emergency Department Visits for Unsupervised Pediatric Medication Exposures
Maribeth C Lovegrove1, Nina J Weidle2, Andrew I Geller1
1Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Insights
Unsupervised medication exposures in young children led to fewer emergency visits from 2009-2020, with significant declines in benzodiazepine and opioid exposures. Continued prevention efforts are crucial for further reductions in these pediatric poisonings.
Area of Science:
- Pediatric Emergency Medicine
- Public Health Surveillance
- Toxicology
Background:
- Unsupervised medication exposures in children under 5 years old historically led to increased emergency department (ED) visits and hospitalizations.
- Prevention initiatives were implemented to address this public health concern.
Purpose of the Study:
- To analyze trends in ED visits for unsupervised medication exposures among young children (≤5 years) in the U.S. from 2009 to 2020.
- To identify specific medications associated with changes in exposure trends.
Main Methods:
- Utilized nationally representative data from the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance (NEISS-CADES) project.
- Analyzed data from 2009 to 2020 to assess overall and medication-specific trends in ED visits for unsupervised exposures in children aged ≤5 years.
- Data analysis was conducted in 2022.
Main Results:
- An estimated 677,968 ED visits for unsupervised medication exposures occurred in children ≤5 years from 2009-2020.
- Significant declines were observed for benzodiazepines, opioids, and over-the-counter cough/cold medications and acetaminophen.
- Increases in exposures were noted for over-the-counter herbal/alternative remedies, particularly melatonin.
Conclusions:
- Estimated ED visits and hospitalizations for unsupervised medication exposures decreased between 2009 and 2020, coinciding with prevention efforts.
- While overall trends improved, specific medication exposures require targeted prevention strategies.
- Continued focused interventions are necessary to further reduce unsupervised medication exposures in young children.
Introduction:
Emergency department visits and hospitalizations for unsupervised medication exposures among young children increased in the early 2000s. Prevention efforts were initiated in response.
Methods:
Nationally representative data from the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance project collected from 2009 to 2020 were analyzed in 2022 to assess overall and medication-specific trends in emergency department visits for unsupervised exposures among children aged ≤5 years.
Results:
From 2009 to 2020, there were an estimated 677,968 (95% CI=550,089, 805,846) emergency department visits for unsupervised medication exposures among children aged ≤5 years in the U.S. Most visits involved children aged 1-2 years (2009-2012 [70.3%], 2017-2020 [67.4%]), and nearly one half involved prescription solid medications (2009-2012 [49.4%], 2017-2020 [48.1%]). The largest declines in estimated numbers of annual visits from 2009-2012 to 2017-2020 were for exposures involving prescription solid benzodiazepines (-2,636 visits, -72.0%) and opioids (-2,596 visits, -53.6%) and over-the-counter liquid cough and cold medications (-1,954 visits, -71.6%) and acetaminophen (-1,418 visits, -53.4%). The estimated number of annual visits increased for exposures involving over-the-counter solid herbal/alternative remedies (+1,028 visits, +65.6%), with the largest increase for melatonin exposures (+1,440 visits, +421.1%). Overall, the estimated number of visits for unsupervised medication exposures decreased from 66,416 in 2009 to 36,564 in 2020 (annual percentage change= -6.0%). Emergent hospitalizations for unsupervised exposures also declined (annual percentage change= -4.5%).
Conclusions:
Declines in estimated emergency department visits and hospitalizations for unsupervised medication exposures from 2009 to 2020 coincided with renewed prevention efforts. Targeted approaches may be needed to achieve continued declines in unsupervised medication exposures among young children.
More Related Videos
Related Concept Videos
Factors Affecting Drug Response: Overview
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Regulation
Drug Delivery: Enteral Route
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...

